Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desflurane for Preventing Postoperative Cognitive Dysfunction
NCT04541823Phase 4Unknown
- Sponsor
- Beijing Chaoyang Hospital
- Start
- May 2021
- Primary completion
- Dec 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, randomised trial of desflurane in Post-operative cognitive dysfunction (POCD) (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: Incidence of postoperative cognitive dysfunction. Status: unknown.
02
Drugs
desflurane
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT04541823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04541823.